Hospital del SAS de Jerez
5
0
2
3
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 5 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 3 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (5)
Sentinel Lymph Node Detection in Gastric Cancer Using a Dual Tracer (Superparamagnetic Iron Oxide and Methylene Blue): A Prospective Study With Histological and OSNA Validation
Role: lead
Incremental Haemodialysis in Incident Patients
Role: collaborator
PREMAPROB. Probiotics to Prevent Necrotizing Enterocolitis
Role: collaborator
Efficacy and Safety of Therapy Against HCV Based on Direct-acting Antivirals in Real-life Conditions
Role: collaborator
Brachial Artery Peak Velocity Variation to Predict Fluid Responsiveness
Role: lead
All 5 trials loaded